In the press release from today they state:
They already mentioned before that they're gonna release it in Q2 2017.
Replicel had a 4-5 year delay because GE removed the culture medium they were using from their market and they had to do a lot of extensive communications with the relevant regulatory authorities to make sure this Phase 1 study is still valid as it uses the GE medium while the final product (and Shisedo study??) don't. Plus of course finding a replacement and checking everything.
------
If this product turns non-permanent hair grafts into permanent ones than it will significantly increase the donor region for hair transplants for most people.
An analysis of injection site biopsies taken 60.5 months after injection is currently ongoing with results expected in the next few weeks.
They already mentioned before that they're gonna release it in Q2 2017.
Replicel had a 4-5 year delay because GE removed the culture medium they were using from their market and they had to do a lot of extensive communications with the relevant regulatory authorities to make sure this Phase 1 study is still valid as it uses the GE medium while the final product (and Shisedo study??) don't. Plus of course finding a replacement and checking everything.
------
If this product turns non-permanent hair grafts into permanent ones than it will significantly increase the donor region for hair transplants for most people.